More articles from Interstitial lung disease

Association between the use of statins and risk of interstitial lung disease/idiopathic pulmonary fibrosis: time-dependent analysis of population-based nationwide data
Hye Jin Jang, Dong Yoon Lee, Gjustina Loloci, Jihyeon Jeong, Won-Il Choi

European Respiratory Journal Jul 2023, 62 (1) 2300291; DOI: 10.1183/13993003.00291-2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial
Julie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, Marie-Sara Agier, Julien Bermudez, Philippe Bonniaud, Raphael Borie, Pierre-Yves Brillet, Jacques Cadranel, Isabelle Court-Fortune, Bruno Crestani, Marie-Pierre Debray, Emmanuel Gomez, Anne Gondouin, Sandrine Hirschi-Santelmo, Dominique Israel-Biet, Stéphane Jouneau, Karine Juvin, Julie Leger, Mallorie Kerjouan, Charles-Hugo Marquette, Jean-Marc Naccache, Hilario Nunes, Laurent Plantier, Grégoire Prevot, Sébastien Quetant, Julie Traclet, Victor Valentin, Yurdagul Uzunhan, Lidwine Wémeau-Stervinou, Theodora Bejan-Angoulvant, Vincent Cottin, Sylvain Marchand-Adam

European Respiratory Journal Jun 2023, 61 (6) 2202071; DOI: 10.1183/13993003.02071-2022
Incidence of interstitial lung abnormalities: the MESA Lung Study
Claire F. McGroder, Spencer Hansen, Karen Hinckley Stukovsky, David Zhang, P. Hrudaya Nath, Mary M. Salvatore, Sushilkumar K. Sonavane, Nina Terry, Justin T. Stowell, Belinda M. D'Souza, Jay S. Leb, Shifali Dumeer, Muhammad U. Aziz, Kiran Batra, Eric A. Hoffman, Elana J. Bernstein, John S. Kim, Anna J. Podolanczuk, Jerome I. Rotter, Ani W. Manichaikul, Stephen S. Rich, David J. Lederer, R. Graham Barr, Robyn L. McClelland, Christine Kim Garcia

European Respiratory Journal Jun 2023, 61 (6) 2201950; DOI: 10.1183/13993003.01950-2022
The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study
Carl J. Reynolds, Fabiola Del Greco M, Richard J. Allen, Carlos Flores, R. Gisli Jenkins, Toby M. Maher, Philip L. Molyneaux, Imre Noth, Justin M. Oldham, Louise V. Wain, Jiyuan An, Jue-Sheng Ong, Stuart MacGregor, Tom A. Yates, Paul Cullinan, Cosetta Minelli

European Respiratory Journal May 2023, 61 (5) 2201585; DOI: 10.1183/13993003.01585-2022
Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis
Katerina Koether, Valérie Besnard, Hilary Sandig, Alan Carruthers, Elena Miranda, Sabine Grootenboer-Mignot, Camille Taillé, Sylvie Chevret, Dominique Valeyre, Hilario Nunes, Dominique Israel-Biet, Wei Keat Lim, Vincent Cottin, Dominic Corkill, Claire Dobson, Maria Groves, Franco Ferraro, Edouard Guenzi, Ling Huang, Michal Sulikowski, Arnaud Mailleux, Lynne Anne Murray, Thomas Mustelin, Ian Strickland, Matthew A. Sleeman, Bruno Crestani

European Respiratory Journal May 2023, 61 (5) 2102381; DOI: 10.1183/13993003.02381-2021
A predictive model for acute exacerbation of idiopathic interstitial pneumonias
Masato Karayama, Yoichiro Aoshima, Takahito Suzuki, Kazutaka Mori, Nobuko Yoshizawa, Shintaro Ichikawa, Shinpei Kato, Koshi Yokomura, Masato Kono, Dai Hashimoto, Yusuke Inoue, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Satoshi Goshima, Naoki Inui, Takafumi Suda

European Respiratory Journal May 2023, 61 (5) 2201634; DOI: 10.1183/13993003.01634-2022
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study
Yet H. Khor, Max Schulte, Kerri A. Johannson, Veronica Marcoux, Jolene H. Fisher, Deborah Assayag, Helene Manganas, Nasreen Khalil, Martin Kolb, Christopher J. Ryerson, for the Austin ILD Registry and CARE-PF Investigators, the ALLIANCE Study Group , Gerard Cox, Charlene D. Fell, Andrea S. Gershon, Nicole Goh, Andrew J. Halayko, Stacey Lok, Julie Morisset, Mohsen Sadatsafavi, Shane Shapera, Teresa To, Pearce G. Wilcox, Alyson W. Wong

European Respiratory Journal May 2023, 61 (5) 2202163; DOI: 10.1183/13993003.02163-2022
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone
Hsiao-Yen Ma, Jason A. Vander Heiden, Salil Uttarwar, Ying Xi, Elsa-Noah N'Diaye, Ryan LaCanna, Patrick Caplazi, Sarah Gierke, John Moffat, Paul J. Wolters, Ning Ding

European Respiratory Journal Apr 2023, 61 (4) 2200604; DOI: 10.1183/13993003.00604-2022
Interstitial lung disease progression after genomic usual interstitial pneumonia testing
Sachin Chaudhary, S. Sam Weigt, Manuel L. Ribeiro Neto, Bryan S. Benn, Janelle Vu Pugashetti, Rebecca Keith, Arista Chand, Scott Oh, Fayez Kheir, Vijaya Ramalingam, Joshua J. Solomon, Richart Harper, Joseph A. Lasky, Justin M. Oldham

European Respiratory Journal Apr 2023, 61 (4) 2201245; DOI: 10.1183/13993003.01245-2022
GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial
Irina R. Strambu, Christian A. Seemayer, Liesbeth M-C.A. Fagard, Paul A. Ford, Tom A.K. Van der Aa, Angela A. de Haas-Amatsaleh, Vikas Modgill, Eva Santermans, Eric N. Sondag, Eric G. Helmer, Toby M. Maher, Ulrich Costabel, Vincent Cottin

European Respiratory Journal Mar 2023, 61 (3) 2201794; DOI: 10.1183/13993003.01794-2022

Main menu

User menu

Search

More articles from Interstitial lung disease

Pages

Contact us